JP Patent

JP2018111713A — ヒドラジド含有核輸送調節因子およびその使用

Assigned to Karyopharm Therapeutics Inc · Expires 2018-07-19 · 8y expired

What this patent protects

【課題】ヒドラジド含有核輸送調節因子およびその使用を提供すること。【解決手段】所定の式Ｉの化合物またはその薬学的に許容可能な塩。【選択図】なし

USPTO Abstract

【課題】ヒドラジド含有核輸送調節因子およびその使用を提供すること。【解決手段】所定の式Ｉの化合物またはその薬学的に許容可能な塩。【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number: JP2018111713A
Jurisdiction: JP
Classification: —
Expires: 2018-07-19
Drug substance claim: No
Drug product claim: No
Assignee: Karyopharm Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.